Search results
Results from the WOW.Com Content Network
The first-ever needle-free alternative to the EpiPen and similar epinephrine autoinjectors has been approved by the Food and Drug Administration to treat anaphylaxis. Neffy, a nasal spray that ...
The spray, which will be sold under the brand name neffy, is seen as an alternative to EpiPen and other autoinjectors that are filled with epinephrine, a life-saving drug used by people at risk of ...
The nasal spray EURneffy is seen as an alternative to EpiPen and other autoinjectors that are filled with epinephrine, a life-saving drug used by people at risk of anaphylaxis and other allergic ...
The EpiPen, manufactured by Meridian Medical Technologies, and marketed by Mylan, has dominated the market. [57] In 2007 when Mylan acquired the rights to market the product, annual sales of all epinephrine autoinjectors were about $200 million and EpiPen had around 90% of the market; in 2015 the market size was around $1.5 billion and Mylan ...
Epinephrine vial 1 mg (Adrenalin). Epinephrine is used to treat a number of conditions, including cardiac arrest, anaphylaxis, and superficial bleeding. [25] It has been used historically for bronchospasm and low blood sugar, but newer treatments for these that are selective for β 2 adrenoceptors, such as salbutamol, are preferred.
Meridian Medical Technologies, LLC is an American company which specialized primarily in developing and manufacturing antidotes for chemical weapons.. It was founded in 1968 as Brunswick Biomedical Corporation and changed its name in November 1996 [1] when it merged with Survival Technology, Inc. [2] Survival Technology, Inc. had been the employer of Sheldon Kaplan, who had invented various ...
The trial was designed to compare single doses of AQST-109 to EpiPen 0.3mg and epinephrine 0.3mg intramuscular (IM) injection and repeat doses of AQST-109 to repeat doses of epinephrine 0.3mg IM ...
A serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI), also known as a triple reuptake inhibitor (TRI), is a type of drug that acts as a combined reuptake inhibitor of the monoamine neurotransmitters serotonin, norepinephrine, and dopamine.